BioNTech CEO Ugur Sahin reveals how Pfizer vaccine was made so fast - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 78 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 35%
  • Publisher: 51%

Deutschland Nachrichten Nachrichten

Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen

We spoke to BioNTech's CEO about how the firm made an effective COVID-19 vaccine so fast and when he plans to get vaccinated

This story is available exclusively to Business Insider subscribers.Little-known biotech firm BioNTech made headlines after the long-awaited phase three data for its vaccine with Pfizer arrived, indicating the first effective coronavirus shot.showed the vaccination worked for 90% of all study participants, exceeding the requirements for approval by the US FDA.

As well as being chief physician for infectious diseases and tropical medicine, Wendtner is the head of the special unit for highly contagious life-threatening infections at the Munich Clinic Schwabing.A rate of 90% is remarkable — many ongoing vaccination studies on Covid-19 currently only require a success rate of at least 50%. This is also the prerequisite for approval by the US FDA. BioNTech and Pfizer are now in the process of applying to the FDA for emergency approval.

Clinical tests were also carried out on a very large scale. It was clear that, even if we could produce a possible vaccine within just a few weeks, clinical tests would take a while as we had to give the vaccine to tens of thousands of people.You need partners at your side for large projects like this — that's why we decided to work with our colleagues at Pfizer.

We called it project "Lightspeed" to make it clear that we're not wasting any time. It was thanks to having a like-minded partner like Pfizer that it was possible to keep the development time so short. For common vaccines you have to grow viruses in the laboratory and then infect cells with these viruses in huge cell cultures, for which you need very large units. And the process that follows is very, very laborious. Only large-scale companies can do that. To put it simply, for an mRNA vaccine I initially only need a 50-liter bioreactor with which I can produce the mRNA. That's the great thing because it's very scalable. The production goes overnight.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

 /  🏆 729. in DE
 

Vielen Dank für Ihren Kommentar.Ihr Kommentar wird nach Prüfung veröffentlicht.

No chance to read this news without being a member👏🏻 it is something that the whole world concerns about but Business Insider is requesting an amount of money equal to minimum average living salary in Turkey. Good job, seriously.

Curse you business insider and your oppressive paywall

thanks

You -Eat junk -Watch news -Watch porn -Live in debt -Don't exercise -Play video games -Smoke&Drink regularly -Have a single source income -Spend time with negative people And then you wonder why your life isn't changing? Follow me to change your life

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen